| Key Financial Ratios of Alembic Pharmaceuticals (in Rs. Cr.) |
Mar 25 |
Mar 24 |
Mar 23 |
Mar 22 |
Mar 21 |
|
| Per Share Ratios |
|
|
|
|
|
|
| Basic EPS (Rs.) |
25.60 |
33.91 |
17.64 |
27.65 |
60.67 |
|
| Diluted EPS (Rs.) |
25.60 |
33.91 |
17.64 |
27.65 |
60.67 |
|
| Cash EPS (Rs.) |
39.69 |
47.70 |
31.53 |
42.15 |
67.56 |
|
| Book Value [ExclRevalReserve]/Share (Rs.) |
264.30 |
249.75 |
224.59 |
269.16 |
267.32 |
|
| Book Value [InclRevalReserve]/Share (Rs.) |
264.30 |
249.75 |
224.59 |
269.16 |
267.32 |
|
| Dividend / Share(Rs.) |
11.00 |
11.00 |
8.00 |
10.00 |
14.00 |
|
| Revenue from Operations/Share (Rs.) |
306.93 |
298.86 |
261.97 |
256.19 |
257.01 |
|
| PBDIT/Share (Rs.) |
48.30 |
52.40 |
33.98 |
48.84 |
80.49 |
|
| PBIT/Share (Rs.) |
34.20 |
38.60 |
20.09 |
34.34 |
72.72 |
|
| PBT/Share (Rs.) |
30.96 |
35.83 |
17.60 |
33.48 |
72.07 |
|
| Net Profit/Share (Rs.) |
25.60 |
33.91 |
17.64 |
27.65 |
59.80 |
|
| Profitability Ratios |
|
|
|
|
|
|
| PBDIT Margin (%) |
15.73 |
17.53 |
12.97 |
19.06 |
31.31 |
|
| PBIT Margin (%) |
11.14 |
12.91 |
7.67 |
13.40 |
28.29 |
|
| PBT Margin (%) |
10.08 |
11.98 |
6.71 |
13.06 |
28.04 |
|
| Net Profit Margin (%) |
8.33 |
11.34 |
6.73 |
10.79 |
23.26 |
|
| Return on Networth / Equity (%) |
9.68 |
13.57 |
7.85 |
10.27 |
22.37 |
|
| Return on Capital Employed (%) |
12.54 |
14.96 |
8.62 |
12.28 |
25.28 |
|
| Return on Assets (%) |
6.65 |
10.41 |
5.65 |
7.68 |
17.34 |
|
| Total Debt/Equity (X) |
0.22 |
0.09 |
0.14 |
0.12 |
0.04 |
|
| Asset Turnover Ratio (%) |
0.86 |
0.94 |
0.78 |
0.73 |
74.54 |
|
| Liquidity Ratios |
|
|
|
|
|
|
| Current Ratio (X) |
1.71 |
2.25 |
1.79 |
1.74 |
2.11 |
|
| Quick Ratio (X) |
0.81 |
1.23 |
0.97 |
0.85 |
0.94 |
|
| Inventory Turnover Ratio (X) |
1.00 |
1.07 |
0.94 |
0.83 |
3.84 |
|
| Dividend Payout Ratio (NP) (%) |
42.97 |
23.59 |
56.68 |
50.62 |
0.00 |
|
| Dividend Payout Ratio (CP) (%) |
27.71 |
16.77 |
31.71 |
33.21 |
0.00 |
|
| Earnings Retention Ratio (%) |
57.03 |
76.41 |
43.32 |
49.38 |
0.00 |
|
| Cash Earnings Retention Ratio (%) |
72.29 |
83.23 |
68.29 |
66.79 |
0.00 |
|
| Valuation Ratios |
|
|
|
|
|
|
| Enterprise Value (Cr.) |
19,385.78 |
19,701.64 |
10,354.51 |
15,179.32 |
19,108.71 |
|
| EV/Net Operating Revenue (X) |
3.21 |
3.35 |
2.01 |
3.01 |
3.78 |
|
| EV/EBITDA (X) |
20.42 |
19.13 |
15.50 |
15.81 |
12.08 |
|
| MarketCap/Net Operating Revenue (X) |
3.03 |
3.29 |
1.89 |
2.89 |
3.76 |
|
| Retention Ratios (%) |
57.02 |
76.40 |
43.31 |
49.37 |
0.00 |
|
| Price/BV (X) |
3.52 |
3.93 |
2.21 |
2.75 |
3.61 |
|
| Price/Net Operating Revenue |
3.03 |
3.29 |
1.89 |
2.89 |
3.76 |
|
| Earnings Yield |
0.03 |
0.03 |
0.04 |
0.04 |
0.06 |
|
Source : Dion Global Solutions Limited
